Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19140


Purpose:

99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms and legs.


Criteria:

Inclusion Criteria: - peripheral acute venous thrombosis diagnosed by vascular ultrasound - is able to give informed consent - is likely to complete the study Exclusion Criteria: - is pregnant - is lactating - has a history of prior severe allergic reactions (anaphylactic response) - prior use of GP IIb/IIIa antagonist (e.g., abciximab, eptifibatide) - has a platelet count <100,000 or history of thrombocytopenia - has a history of stroke - has a history of recent bleeding documented by decreasing hemoglobin (>1 gm) in last 7 days


NCT ID:

NCT00808626


Primary Contact:

Study Director
Alan H Maurer, MD
Temple University Hospital


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19140
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.